The stock of Novartis AG ADR (NVS) has gone down by -1.85% for the week, with a -7.81% drop in the past month and a -12.53% drop in the past quarter. The volatility ratio for the week is 0.85%, and the volatility levels for the past 30 days are 0.88% for NVS. The simple moving average for the past 20 days is -2.41% for NVS’s stock, with a -4.42% simple moving average for the past 200 days.
Is It Worth Investing in Novartis AG ADR (NYSE: NVS) Right Now?
The price-to-earnings ratio for Novartis AG ADR (NYSE: NVS) is above average at 11.88x, Company’s 36-month beta value is 0.56.Analysts have differing opinions on the stock, with 1 analysts rating it as a “buy,” 0 as “overweight,” 11 as “hold,” and 0 as “sell.”
The public float for NVS is 1.96B, and currently, short sellers hold a 0.24% ratio of that floaft. The average trading volume of NVS on December 04, 2024 was 1.13M shares.
NVS) stock’s latest price update
The stock price of Novartis AG ADR (NYSE: NVS) has plunged by -2.55 when compared to previous closing price of 104.56, but the company has seen a -1.85% decline in its stock price over the last five trading sessions. zacks.com reported 2024-12-04 that The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here’s why you should take advantage.
Analysts’ Opinion of NVS
BofA Securities, on the other hand, stated in their research note that they expect to see NVS reach a price target of $130, previously predicting the price at $135. The rating they have provided for NVS stocks is “Neutral” according to the report published on September 11th, 2024.
NVS Trading at -7.53% from the 50-Day Moving Average
After a stumble in the market that brought NVS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -15.74% of loss for the given period.
Volatility was left at 0.88%, however, over the last 30 days, the volatility rate increased by 0.85%, as shares sank -6.95% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -12.58% lower at present.
During the last 5 trading sessions, NVS fell by -1.96%, which changed the moving average for the period of 200-days by -0.92% in comparison to the 20-day moving average, which settled at $104.40. In addition, Novartis AG ADR saw 0.91% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at NVS starting from Kowalski Robert William, who proposed sale 6,566 shares at the price of $111.72 back on Aug 12 ’24. After this action, Kowalski Robert William now owns shares of Novartis AG ADR, valued at $733,572 using the latest closing price.
Stock Fundamentals for NVS
Current profitability levels for the company are sitting at:
- 0.27 for the present operating margin
- 0.75 for the gross margin
The net margin for Novartis AG ADR stands at 0.35. The total capital return value is set at 0.18. Equity return is now at value 28.87, with 10.88 for asset returns.
Based on Novartis AG ADR (NVS), the company’s capital structure generated 0.41 points at debt to capital in total, while cash flow to debt ratio is standing at 0.53. The debt to equity ratio resting at 0.7. The interest coverage ratio of the stock is 14.34.
Currently, EBITDA for the company is 18.29 billion with net debt to EBITDA at 0.94. When we switch over and look at the enterprise to sales, we see a ratio of 4.37. The receivables turnover for the company is 6.13for trailing twelve months and the total asset turnover is 0.48. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.11.
Conclusion
In a nutshell, Novartis AG ADR (NVS) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
